Trial intelligence / Profile preview

Folic Acid for Prevention of Contrast Induced Nephropathy

NCT02444013Phase 4Unknown

Sponsor
The Third Affiliated Hospital of Sun Yat-sen University
Start
May 2015
Primary completion
May 2017
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of folic acid in contrast-induced nephropathy (CIN), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Status: unknown.

02

Drugs

folic acid
03

Conditions

contrast-induced nephropathy (CIN)

Beyond the preview

Go deeper on NCT02444013.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02444013.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call